Intranasal Oxytocin Therapy Shows No Benefit for Children With ASD
For children with ASD, the administration of intranasal oxytocin therapy during a 24-week period does not significantly improve the score for a measure of social interaction.
For children with ASD, the administration of intranasal oxytocin therapy during a 24-week period does not significantly improve the score for a measure of social interaction.
The investigators sought to determine the down-staging success rate and intention-to-treat outcomes according to uniform criteria in patients with hepatocellular carcinoma.
A preemptive intervention reduces behaviors associated with ASD when used at the time atypical development first emerges during infancy.
Investigators examined the relationship between maternal prepregnancy BMI status and autism spectrum disorder and developmental disorders in offspring.
Study researchers investigated the genetic overlap between ADHD and autism to determine if shared gene variants may provide insight into treatment targets.
Investigators attempted to analyze the link between celiac disease and autism spectrum disorder based on previously published research.
Prenatal exposure to acetaminophen is associated with higher odds of symptoms of ADHD and autism spectrum conditions.
An app that elicits and quantifies eye-gaze patterns of toddlers could differentiate between those with and without ASDs.
Adolescents with autism are more likely to have physical difficulties and additional mental health compared with general population controls.
Exposure to epidural labor analgesia (ELA) is not associated with offspring risk for autism spectrum disorder.